专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

EP4205733B1 COMPOSITION FOR THE TREATMENT OF OSTEOPENIA AND OSTEOPOROSIS 有权转让
公开(公告)号：EP4205733B1
公开(公告)日：2024-10-23
申请号：EP22216685.2
申请日：2022-12-27
IPC分类号： A61K31/05 , A61K31/122 , A61K31/352 , A61K31/80 , A61K36/9066 , A61P19/10
CPC分类号： A61K31/122 , A61K31/352 , A61K36/9066 , A61P19/10 , A61K33/00 , A61K31/7034

2. 发明公开

EP4215194A1 COMBINATION THERAPY 审中-实审
公开(公告)号：EP4215194A1
公开(公告)日：2023-07-26
申请号：EP23161550.1
申请日：2012-01-11
申请人： Dimerix Bioscience Pty Ltd
发明人： PFLEGER, Kevin Donald George , MCCALL, Elizabeth , WILLIAMS, James
IPC分类号： A61K31/41 , A61K31/80 , A61P9/06 , A61K31/537 , A61P9/00 , A61P9/12 , A61P13/12
摘要： The invention relates to pharmaceutical compositions comprising: (a) at least one angiotensin receptor blocker or a pharmaceutically acceptable salt thereof, and (b) at least one chemokine receptor pathway inhibitor or a pharmaceutically acceptable salt thereof. The invention also relates to pharmaceutical compositions comprising: (a) at least one angiotensin receptor blocker or a pharmaceutically acceptable salt thereof; and (b) at least one chemokine receptor pathway inhibitor or a pharmaceutically acceptable salt thereof which inhibits a component of the chemokine receptor pathway other than the chemokine receptor. Oral sustained release pharmaceutical compositions comprising the pharmaceutical composition, as well as injectable sustained release pharmaceutical compositions comprising the pharmaceutical composition are described. The invention further relates to tablets, capsules, injectable suspensions, and compositions for pulmonary or nasal delivery comprising the pharmaceutical composition. Also described are: methods for assessing the efficacy of the pharmaceutical composition; methods for assessing the inhibition or partial inhibition activity of the pharmaceutical composition; methods for the treatment, amelioration or prevention of a condition or disease comprising administering to a subject a therapeutically effective amount of the pharmaceutical composition; and the use of the pharmaceutical composition for the manufacture of a dosage form for the treatment of a disease.

4. 发明公开

EP4054534A1 COMPOSITION AND FORMULATION FOR THE TREATMENT OF INTESTINAL GAS AND BLOATING 审中-实审
公开(公告)号：EP4054534A1
公开(公告)日：2022-09-14
申请号：EP20800732.8
申请日：2020-10-22
申请人： Biofarma S.r.l.
发明人： VERSOLATO, Daniele , VATRI, Elena
IPC分类号： A61K9/14 , A61K47/26 , A61K31/80 , A61K38/54 , A61P1/14

5. 发明公开

EP4003370A1 A COMPOSITION COMPRISING SIMETHICONE AND SUCROSE ESTERS AND USE THEREOF AS AN ANTIFOAM AGENT 审中-实审
公开(公告)号：EP4003370A1
公开(公告)日：2022-06-01
申请号：EP20758346.9
申请日：2020-07-24
申请人： S.I.I.T. S.r.l.-Servizio Internazionale Imballaggi Termosaldanti
发明人： COSTA, Andrea Domizio , MADARO, Elena , DOMINONI, Mirko
IPC分类号： A61K31/80 , A61K31/7024 , A61P1/16

6. 发明授权

EP2852600B1 BISPHOSPHONATES VINYLIC MONOMERS AND POLYMERS AND USES THEREOF 有权转让
公开(公告)号：EP2852600B1
公开(公告)日：2021-10-13
申请号：EP13794482.3
申请日：2013-05-20
发明人： MARGEL, Shlomo , MIZRAHI, Dana , GLUZ, Eran , CHEN, Ravit
IPC分类号： A61K47/69 , C07F9/38 , A61K9/51 , A61K31/663 , A61K31/05 , A61K31/215 , A61P19/00 , A61K45/06 , A61K9/16 , A61K49/00 , A61K31/80 , C07F9/6558 , C08F220/60

7. 发明授权

EP3141243B1 PHARMACEUTICAL COMPOSITION 有权转让
公开(公告)号：EP3141243B1
公开(公告)日：2020-07-08
申请号：EP15789186.2
申请日：2015-05-08
申请人： The University of Tokyo
发明人： KATAOKA, Kazunori , ISHII, Takehiko , NAITO, Mitsuru , YOSHINAGA, Naoto , ENDO, Taisuke
IPC分类号： A61K31/80 , A61K9/107 , A61K31/7105 , A61K31/711 , A61K47/34 , A61K48/00

8. 发明公开

EP3442502A1 COMPOSITIONS, SYSTEMS, KITS, AND METHODS FOR TREATING AN INFECTION 审中-公开
公开(公告)号：EP3442502A1
公开(公告)日：2019-02-20
申请号：EP17783103.9
申请日：2017-04-13
申请人： Novan, Inc.
发明人： DOXEY, Ryan , STASKO, Nathan , MARTIN, Megan
IPC分类号： A61K9/10 , A61K31/80 , A61P17/02

9. 发明授权

EP2790676B1 SIMETHICONE FORMULATION 有权
标题翻译： SIMETHICONE配方
公开(公告)号：EP2790676B1
公开(公告)日：2018-01-10
申请号：EP12819146.7
申请日：2012-12-11
申请人： Disphar International B.V.
发明人： VELADA, José Luis , DOSHI, Hiteshkumar Anilkant , TENDULKAR, Anjali Rajesh , SHINDE, Vicky
IPC分类号： A61K9/20 , A61K31/451 , A61K31/445 , A61K31/80
CPC分类号： A61K9/2036 , A61K9/2009 , A61K9/2018 , A61K31/445 , A61K31/451 , A61K31/80
摘要： The present invention relates to solid pharmaceutical formulations based on simethicone and calcium phosphate and mannitol.

10. 发明公开

EP2724733A1 HYDROPHOBIC POLYMER COMPOUND HAVING ANTICOAGULANT EFFECT 审中-公开
标题翻译：疏水聚合物复合物具有抗凝效果
公开(公告)号：EP2724733A1
公开(公告)日：2014-04-30
申请号：EP12803272.9
申请日：2012-06-22
申请人： Toray Industries, Inc.
发明人： TANAHASHI, Kazuhiro , SAKAGUCHI, Hirokazu , SAKAGUCHI, Yuka
IPC分类号： A61L31/00 , A61K31/80 , A61K47/34 , A61K47/48 , A61M1/18 , A61P7/02 , A61K38/55
CPC分类号： A61L33/068 , A61K31/795 , A61K31/80 , A61L27/34 , A61L33/0011 , A61L33/06 , A61M1/3672 , A61M1/3673 , C08G77/46 , C08G81/00 , C08J7/047 , C08J2300/22 , C08J2400/10 , C08J2483/12 , C08L83/12 , C09D183/12
摘要： The present invention provides a hydrophobic polymer compound capable of inhibiting the blood coagulation reactions in both the primary hemostasis stage involving platelets and the coagulation thrombus formation stage involving blood coagulation factors, which hydrophobic polymer compound can be firmly immobilized on the surface of a medical device or medical material in a state where the compound retains its anticoagulant activity. The present invention provides a hydrophobic polymer compound in which a polymer compound inhibiting platelet adhesion is bound with a compound inhibiting blood coagulation reaction.
摘要翻译：本发明提供一种疏水性高分子化合物，其能够在涉及血小板的一级止血阶段和涉及血液凝固因子的凝血栓形成阶段两者中抑制凝血反应，所述疏水性高分子化合物可牢固地固定在医疗器械的表面上或在化合物保持其抗凝血活性的状态下的医疗材料。本发明提供疏水性高分子化合物，其中抑制血小板粘附的高分子化合物与抑制凝血反应的化合物结合。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式